Gonadotropin, Chorionic

CHEMBL1201509 Phase 4 Approved Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

A hormone naturally produced during pregnancy that maintains the corpus luteum and stimulates progesterone production, used medically to treat infertility, undescended testicles in boys, and as a supportive treatment in certain cancer investigations. In fertility treatment, it triggers final egg maturation and ovulation. It has also been studied in the context of obesity management and various hormonal conditions.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A hormone naturally produced during pregnancy that maintains the corpus luteum and stimulates progesterone production, used medically to treat infertility, undescended testicles in boys, and as a supportive treatment in certain cancer investigations. In fertility treatment, it triggers final egg maturation and ovulation. It has also been studied in the context of obesity management and various hormonal conditions.

Yes, Gonadotropin, Chorionic is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201509. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.